Company: JPC
Filing Date: 2025-10-03
Form Type: N-CSR
Source: 0001193125-25-230231
Chunk: 0

Company: Nuveen Preferred & Income Opportunities Fund
Filing Date: 2025-10-03
Form: N-CSR
Chunk 0
---
 Report                                  |     | 152 |
| Statement Regarding Basis for Approval of Investment Advisory Contract |     | 153 |
| Board Members & Officers                                               |     | 160 |

| 2 |

Important Notices JFR – Rights offering:On January 8, 2025, the Board of Trustees (the “Board”) approved the terms of the issuance of transferable rights (“Rights”) to the holders of the Fund’s common shares (par value $0.01 per share) (“Common Shares”) as of January 21, 2025 (the “Record Date”). Holders of Common Shares on the Record Date (“Record Date Shareholders”) received one Right for each outstanding Common Share owned on the Record Date. The Rights entitled the holders to purchase one new Common Share for every 5 Rights held (1‑for‑5), for an aggregate of up to an additional 26,911,238 Common Shares. Holders of Rights were entitled to subscribe for additional Common Shares (the “Offer”) at a discount to the market price of the Common Shares, prior to 5:00 p.m., Eastern time, on February 19, 2025 (the “Expiration Date”). The subscription price per Common Share (the “Subscription Price”) was $8.20 per Common Share, which was equal to 90% of the Fund’s net asset value per Common Share at the close of trading on the NYSE on the Expiration Date. The gross proceeds of the Offer were approximately $220.7 million. The Offer was over-subscribed; however, the Fund did not exercise the secondary oversubscription privilege. The available primary over-subscription shares were allocated pro‑rata among those fully exercising record date shareholders who over-subscribed based on the number of rights originally issued to them by the Fund. The Common Shares subscribed for were issued on February 25, 2025, after completion of the pro‑rata allocation of Common Shares in respect of the primary oversubscription privilege and receipt of all shareholder payments. More details about the Fund’s rights offering are available on www.nuveen.com/cef. JQC – Rights offering:On March 19, 2025, the Board approved the terms of the issuance of transferable rights (“Rights”) to the holders of the Fund’s common shares (par value $0.01 per share) (“Common Shares”) as of March 31, 2025 (the “Record Date”). Holders of Common Shares on the Record Date (“Record Date Share